Description
Seeking Men and Women over 18 years of age with moderately to severely active ulcerative colitis for participation in a study of an investigational product called Efavaleukin Alfa
Overview
We are studying the effect and safety of an investigational product called Efavaleukin Alfa for individuals with moderately to severely active ulcerative colitis.
What we're hoping for
Efavaleukin Alfa for individuals with moderately to severely active ulcerative colitis.
Additional Information
ClinicalTrials.gov Identifier: NCT04987307